An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.
Matteo FerroMihai Dorin VartolomeiGiorgio Ivan RussoFrancesco CantielloAbdal Rahman Abu FarhanDaniela TerraccianoAmelia CimminoSavino Di StasiGennaro MusiRodolfo HurleVincenzo SerrettaGian Maria BusettoEttore De BerardinisAntonio CioffiSisto PerdonàMarco BorghesiRiccardo SchiavinaGabriele CozziGilberto L AlmeidaPierluigi BoveEstevao LimaGiovanni GrimaldiDeliu Victor MateiNicolae CrisanMatteo MutoPaolo VerzeMichele BattagliaGiorgio GuazzoniRiccardo AutorinoGiuseppe MorgiaRocco DamianoOttavio de CobelliShahrokh ShariatVincenzo MironeGiuseppe LucarelliPublished in: World journal of urology (2018)
The BMI could have a relevant role in the clinical management of T1G3 NMIBC, if associated with bladder cancer recurrence and progression. In particular, this anthropometric factor should be taken into account at initial diagnosis and in therapeutic strategy decision making.